Presentation TCT 2016 Stable Angina Decision-making: PCI vs CABG vs OMT Presenter: Tayo A. Addo, Robert T. Pyo October 30, 2016
Presentation TCT 2016 Integration of the Extended Heart Team for Clinical Decision-Making in Patients With Aortic Stenosis Presenter: Marian C. Hawkey, Amanda M Kirby October 30, 2016
Presentation TCT 2016 How to Interpret Hemodynamic and Echo Data for Transcatheter Mitral Valve Repair Clinical Decision-Making and Procedural Guidance Presenter: Jeff Davis, James B. Hermiller Jr. October 29, 2016
Presentation TCT 2016 How to Interpret Hemodynamic, CT, and Echo Data for TAVR Clinical Decision-making and Procedural Guidance Presenter: Thomas H. Maloney, Paul D. Mahoney October 29, 2016
News Conference News TCT 2016 YELLOW II: Improved Cholesterol Efflux Linked to Plaque Stabilization in Statin-Treated Patients Michael O'Riordan October 29, 2016
News Conference News TCT 2016 Impella CP Fails to Show Benefit in Exploratory Study of Patients With Severe Cardiogenic Shock Todd Neale October 29, 2016
News Conference News TCT 2015 IBIS-4: Rosuvastatin Tied to Plaque Stability in STEMI Yael L. Maxwell October 16, 2015
Presentation TCT 2015 Left Main Stent Technique and Decision Making: What We Have Learned From the ISAR LEFT Main I and II Trials Presenter: Nicholas J. Lembo, Patrick W. Serruys, Julinda Mehilli October 15, 2015
Presentation TCT 2015 Left Main Stent Technique and Decision Making: What We Have Learned From the DELTA Registry Presenter: Nicholas J. Lembo, Patrick W. Serruys, Alaide Chieffo October 15, 2015
Presentation TCT 2015 Left Main Stent Technique and Decision Making: What We Have Learned From the MITO Study Presenter: Nicholas J. Lembo, Patrick W. Serruys, Sunao Nakamura October 15, 2015
Presentation TCT 2015 Will Successful Adoption of Fenestrated/Branched Grafts in Complex Anatomy Improve Overall Patient Outcomes by Decreasing Off-label Usage of Standard EVAR Devices? Presenter: Clifford J. Buckley, Zvonimir Krajcer, Christopher J. Kwolek October 15, 2015
Presentation TCT 2015 Is AAA Incidence on the Decline in the United States, Thereby Limiting the Value of Screening? Presenter: Clifford J. Buckley, Zvonimir Krajcer, Christopher K. Zarins October 15, 2015
Presentation TCT 2015 Stroke After TAVR 1: Reassessing Incidence (Declining), Etiologic Factors, and Remaining Controversies Presenter: Samir R. Kapadia, Nicolas M. Van Mieghem October 15, 2015
Presentation TCT 2015 Optimal Pharmacology in the Diabetic: What's Here? What's New? What's in the Pipeline? Presenter: Frederick Feit, David J. Maron, Norman E. Lepor October 15, 2015
Presentation TCT 2015 Do Contemporary DES Change the Equation for PCI vs CABG in the Diabetic Patient? Presenter: Frederick Feit, David J. Maron, Sripal Bangalore October 15, 2015
Presentation TCT 2015 Pros and Cons of CABG vs PCI in the Diabetic Patient With Multivessel Disease: Insights From Randomized Trials Presenter: Frederick Feit, David J. Maron, Michael E. Farkouh October 15, 2015
News Conference News TCT 2015 Valve-in-Valve TAVR Benefits Patients with Failing Surgical Bioprosthetic Valves Todd Neale October 15, 2015
News Conference News TCT 2015 RESPECT Confirms Long-term Safety, Efficacy of PFO Closure for Recurrent Stroke Nicole Lou October 15, 2015
News Conference News TCT 2015 Low 1-Year Event Rates Seen After TAVR With Sapien 3 Todd Neale October 15, 2015